Search Results - "Lam, Kwong Yok"

The diagnosis and management of NK/T-cell lymphomas by Tse, Eric, Kwong, Yok-Lam

“…Extranodal natural killer (NK)/T-cell lymphoma is an aggressive malignancy of putative NK-cell origin, with a minority deriving from the T-cell lineage…”
Get full text

EBV Viral Loads in Diagnosis, Monitoring, and Response Assessment by Kimura, Hiroshi, Kwong, Yok-Lam

“…The quantification of circulating Epstein Barr virus (EBV) DNA loads has played an important role in the diagnosis and management of EBV-associated lymphoid…”
Get full text

Oral arsenic trioxide, all‐trans retinoic acid, and ascorbic acid maintenance after first complete remission in acute promyelocytic leukemia: Long‐term results and unique prognostic indicators by Gill, Harinder S., Yim, Rita, Kumana, Cyrus R., Tse, Eric, Kwong, Yok‐Lam

“…Background The role of arsenic trioxide (As2O3) in the maintenance of first complete remission (CR1) in acute promyelocytic leukemia (APL) is unclear. Methods…”
Get full text

Arsenic trioxide inhibits anaplastic lymphoma kinase (ALK)‐positive diffuse large B‐cell lymphoma through targeting ALK‐fusion oncoprotein by Yue, Lok‐Man, Chau, David, Kwong, Yok‐Lam, Tse, Eric

Get full text

How we treat NK/T-cell lymphomas by Tse, Eric, Zhao, Wei-Li, Xiong, Jie, Kwong, Yok-Lam

“…Natural killer (NK)/T-cell lymphomas are aggressive malignancies with a predilection for Asian and South American populations. Epstein-Barr virus (EBV)…”
Get full text

Phase II Study of SMILE Chemotherapy for Newly Diagnosed Stage IV, Relapsed, or Refractory Extranodal Natural Killer (NK)/T-Cell Lymphoma, Nasal Type: The NK-Cell Tumor Study Group Study by YAMAGUCHI, Motoko, KWONG, Yok-Lam, SUZUMIYA, Junji, KODAMA, Takao, KIMURA, Hiroshi, HYO, Rie, NAKAMURA, Shigeo, OSHIMI, Kazuo, SUZUKI, Ritsuro, WON SEOG KIM, MAEDA, Yoshinobu, HASHIMOTO, Chizuko, SUH, Cheolwon, IZUTSU, Koji, ISHIDA, Fumihiro, ISOBE, Yasushi, SUEOKA, Eisaburo

“…To explore a more effective treatment for newly diagnosed stage IV, relapsed, or refractory extranodal natural killer/T-cell lymphoma, nasal type (ENKL), we…”
Get full text

PD1 blockade with low-dose nivolumab in NK/T cell lymphoma failing l-asparaginase: efficacy and safety by Chan, Thomas S. Y., Li, Jamilla, Loong, Florence, Khong, Pek-Lan, Tse, Eric, Kwong, Yok-Lam

Get full text

Phase I study of dexamethasone, methotrexate, ifosfamide, l‐asparaginase, and etoposide (SMILE) chemotherapy for advanced‐stage, relapsed or refractory extranodal natural killer (NK)/T‐cell lymphoma and leukemia by Yamaguchi, Motoko, Suzuki, Ritsuro, Kwong, Yok‐Lam, Kim, Won Seog, Hasegawa, Yuichi, Izutsu, Koji, Suzumiya, Junji, Okamura, Takayuki, Nakamura, Shigeo, Kawa, Keisei, Oshimi, Kazuo

“…Extranodal natural killer (NK)/T‐cell lymphoma, nasal type, and aggressive NK‐cell leukemia are rare, and their standard therapy has not been established. They…”
Get full text

CD3+CD4+ lymphoid neoplasm: diagnostic clues for plasmablastic lymphoma instead of peripheral T-cell lymphoma by Gill, Harinder, Au-Yeung, Rex, Loong, Florence, Kwong, Yok-Lam

Get full text

Chidamide in the treatment of peripheral T-cell lymphoma by Chan, Thomas S, Tse, Eric, Kwong, Yok-Lam

“…Mature T-cell lymphomas are aggressive malignancies. Treatment outcome is poor with conventional chemotherapy. They are about twice as common in Asia as…”
Get full text

STAT3 gene mutations and their association with pure red cell aplasia in large granular lymphocyte leukemia by Ishida, Fumihiro, Matsuda, Kazuyuki, Sekiguchi, Nodoka, Makishima, Hideki, Taira, Chiaki, Momose, Kayoko, Nishina, Sayaka, Senoo, Noriko, Sakai, Hitoshi, Ito, Toshiro, Kwong, Yok‐Lam

“…Large granular lymphocyte leukemia (LGL L) has been morphologically characterized as a group of lymphoproliferative diseases that include T‐cell large granular…”
Get full text

Recent Advances in the Diagnosis and Treatment of Natural Killer Cell Malignancies by Tse, Eric, Kwong, Yok-Lam

“…Natural killer (NK)/T-cell lymphomas are aggressive malignancies. Epstein-Barr virus (EBV) infection in lymphoma cells is invariable. NK/T-cell lymphomas are…”
Get full text

The thrombopoietin mimetics eltrombopag and romiplostim in the treatment of refractory aplastic anaemia by Gill, Harinder, Leung, Garret M. K., Lopes, David, Kwong, Yok‐Lam

Get full text

CD3+/CD56+ EBV+ neoplasms in the nose and upper aerodigestive tract: potential misdiagnosis of plasma cell malignancies as NK/T cell lymphoma by Au-Yeung, Rex, Loong, Florence, Kwong, Yok-Lam

Get full text

Long‐term outcome of relapsed acute promyelocytic leukemia treated with oral arsenic trioxide‐based reinduction and maintenance regimens: A 15‐year prospective study by Gill, Harinder, Yim, Rita, Lee, Harold K. K., Mak, Vivien, Lin, Shek‐Ying, Kho, Bonnie, Yip, Sze‐Fai, Lau, June S. M., Li, Wah, Ip, Ho‐Wan, Hwang, Yu‐Yan, Chan, Thomas S. Y., Tse, Eric, Au, Wing‐Yan, Kumana, Cyrus R., Kwong, Yok‐Lam

“…BACKGROUND For patients who have acute promyelocytic leukemia (APL) in second complete remission (CR2), optimal postremission strategies remain undefined…”
Get full text

Editorial: Acute promyelocytic leukemia - towards a chemotherapy-free approach to cure in all patients, Volume II by Gill, Harinder, Russell, Nigel, Kwong, Yok-Lam

Get full text

Hepatitis B reactivation in occult viral carriers undergoing hematopoietic stem cell transplantation: A prospective study by Seto, Wai‐Kay, Chan, Thomas Sau‐Yan, Hwang, Yu‐Yan, Wong, Danny Ka‐Ho, Fung, James, Liu, Kevin Sze‐Hang, Gill, Harinder, Lam, Yuk‐Fai, Lau, Eric H.Y., Cheung, Ka‐Shing, Lie, Albert K.W., Lai, Ching‐Lung, Kwong, Yok‐Lam, Yuen, Man‐Fung

“…Hepatitis B virus (HBV) reactivation in hepatitis B surface antigen (HBsAg)–negative, antibody to hepatitis B core antigen (anti‐HBc)–positive patients after…”
Get full text

Epstein Barr virus-associated lymphoproliferative diseases: the virus as a therapeutic target by Tse, Eric, Kwong, Yok-Lam

“…Epstein Barr virus (EBV)-associated lymphoproliferative diseases (LPDs) express all EBV latent antigens (type III latency) in immunodeficient patients and…”
Get full text

Sorafenib and omacetaxine mepesuccinate as a safe and effective treatment for acute myeloid leukemia carrying internal tandem duplication of Fms‐like tyrosine kinase 3 by Zhang, Chunxiao, Lam, Stephen S. Y., Leung, Garret M. K., Tsui, Sze‐Pui, Yang, Ning, Ng, Nelson K. L., Ip, Ho‐Wan, Au, Chun‐Hang, Chan, Tsun‐Leung, Ma, Edmond S. K., Yip, Sze‐Fai, Lee, Harold K. K., Lau, June S. M., Luk, Tsan‐Hei, Li, Wa, Kwong, Yok‐Lam, Leung, Anskar Y. H.

“…Background Omacetaxine mepesuccinate (OME) has antileukemic effects against acute myeloid leukemia (AML) carrying an internal tandem duplication of Fms‐like…”
Get full text

Epstein-Barr virus–positive diffuse large B-cell lymphoma after frontline brentuximab vedotin treatment of classical Hodgkin lymphoma by Tse, Eric, Au-Yeung, Rex, Chau, David, Hwang, Yu-Yan, Loong, Florence, Kwong, Yok-Lam

Get full text